torsemide · Sarfe Pharms · NDA 213218
Soaanz
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10154963 | drug product | 6 Oct 2033 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 217239, Micro Labs · 213218-001Approved 1 May 2026Detected 25 Oct 2026Historical import
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 213218 · 001 · RLD · discontinued | tablet, oral | 20MG | 6 Oct 2033 |
| 213218 · 002 · RLD · discontinued | tablet, oral | 60MG | 6 Oct 2033 |
| 213218 · 003 · RLD | tablet, oral | 40MG | open |